Christopher Wilfong
Fondateur chez 76bio, Inc.
Profil
Christopher Wilfong was the founder of Kronos Bio, Inc. (founded in 2017) and served as the Chief Operating Officer.
Mr. Wilfong is also the founder of 76Bio, Inc. Mr. Wilfong's current job is as an Operating Partner at Two River Group Holdings LLC since 2005.
Mr. Wilfong completed his undergraduate degree at The Wharton School of the University of Pennsylvania in 2005 and obtained an MBA from MIT Sloan School of Management in 2012.
Postes actifs de Christopher Wilfong
Sociétés | Poste | Début |
---|---|---|
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Fondateur | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Private Equity Investor | 01/05/2005 |
Anciens postes connus de Christopher Wilfong
Sociétés | Poste | Fin |
---|---|---|
KRONOS BIO, INC. | Fondateur | - |
Formation de Christopher Wilfong
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
KRONOS BIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Health Technology |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Finance |